Patents by Inventor Mikko Iivari Kettunen

Mikko Iivari Kettunen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9259490
    Abstract: A hyperpolarized MR imaging medium and a method of 13C-MR detection using a hyperpolarized MR imaging medium for the determination of lactate dehydrogenase (LDH) activity. The contrast media comprises hyperpolarized [13C, 2H]lactate.
    Type: Grant
    Filed: May 2, 2011
    Date of Patent: February 16, 2016
    Assignee: GE HEALTHCARE LIMITED
    Inventors: Kevin Brindle, Mikko Iivari Kettunen, Brett W.C. Kennedy
  • Patent number: 8951500
    Abstract: The invention relates to method of 13C-MR imaging and/or 13C-MR spectroscopy of cell death using an imaging medium which comprises hyperpolarized 13C-pyruvate.
    Type: Grant
    Filed: August 17, 2007
    Date of Patent: February 10, 2015
    Assignee: GE Healthcare AS
    Inventors: Kevin M. Brindle, Samuel Evan Day, Mikko Iivari Kettunen
  • Publication number: 20130052141
    Abstract: A hyperpolarized MR imaging medium and a method of 13C-MR detection using a hyperpolarized MR imaging medium for the determination of lactate dehydrogenase (LDH) activity. The contrast media comprises hyperpolarised [13C, 2H]lactate.
    Type: Application
    Filed: May 2, 2011
    Publication date: February 28, 2013
    Applicant: GE HEALTHCARE LIMITED
    Inventors: Kevin Brindle, Mikko Iivari Kettunen, Brett W.C. Kennedy
  • Publication number: 20100226859
    Abstract: The invention relates to method of 13C-MR imaging and/or 13C-MR spectroscopy of cell death using an imaging medium which comprises hyperpolarised 13C-pyruvate.
    Type: Application
    Filed: August 17, 2007
    Publication date: September 9, 2010
    Inventors: Kevin M. Brindle, Samuel Evan Day, Mikko Iivari Kettunen